New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

by Technical University MunichProposed mechanism and hypothetical models of IAPP/ACM nanofiber co-assembly versus IAPP amyloid self-assembly. The lower part, IAPP self-assembly into toxic oligome
Neurology April 08,2024
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

by Technical University MunichProposed mechanism and hypothetical models of IAPP/ACM nanofiber co-assembly versus IAPP amyloid self-assembly. The lower part, IAPP self-assembly into toxic oligome
Neurology April 08,2024
Alzheimer's disease research sheds new light on medication side effects

Alzheimer's disease research sheds new light on medication side effects

by Danielle Aiken,Western Sydney UniversityCredit: Unsplash/CC0 Public DomainA new study led by Western Sydney University has shed new light on the treatment of Alzheimer's disease, after re
Neurology April 08,2024
Alzheimer's disease research sheds new light on medication side effects

Alzheimer's disease research sheds new light on medication side effects

by Danielle Aiken,Western Sydney UniversityCredit: Unsplash/CC0 Public DomainA new study led by Western Sydney University has shed new light on the treatment of Alzheimer's disease, after re
Neurology April 08,2024
Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

by Institut PasteurThe specific VHH antibody for plaques, labeled with a green fluorochrome, is injected into mice. The VHH travels along the blood vessels before marking the plaques in the brain. Pho
Neurology April 08,2024
Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

Diagnosis of Alzheimer's disease: Llama antibodies detect cerebral lesions

by Institut PasteurThe specific VHH antibody for plaques, labeled with a green fluorochrome, is injected into mice. The VHH travels along the blood vessels before marking the plaques in the brain. Pho
Neurology April 08,2024
Racial differences in Alzheimer's disease unveiled

Racial differences in Alzheimer's disease unveiled

by Washington University School of MedicineCredit: CC0 Public DomainAfrican-Americans may be twice as likely as Caucasian Americans to develop Alzheimer's disease, but nobody knows why becaus
Neurology April 08,2024
Racial differences in Alzheimer's disease unveiled

Racial differences in Alzheimer's disease unveiled

by Washington University School of MedicineCredit: CC0 Public DomainAfrican-Americans may be twice as likely as Caucasian Americans to develop Alzheimer's disease, but nobody knows why becaus
Neurology April 08,2024
Neuroprotective mechanism altered by Alzheimer's disease risk genes

Neuroprotective mechanism altered by Alzheimer's disease risk genes

by Molly Chiu,Baylor College of MedicineCredit: Baylor College of MedicineThe brain has a natural protective mechanism against Alzheimer's disease, and researchers at Baylor College of Medic
Neurology April 08,2024
Neuroprotective mechanism altered by Alzheimer's disease risk genes

Neuroprotective mechanism altered by Alzheimer's disease risk genes

by Molly Chiu,Baylor College of MedicineCredit: Baylor College of MedicineThe brain has a natural protective mechanism against Alzheimer's disease, and researchers at Baylor College of Medic
Neurology April 08,2024
Blood test for Alzheimer's disease predicts future cognitive decline in healthy people

Blood test for Alzheimer's disease predicts future cognitive decline in healthy people

by Brigham and Women's HospitalCredit: CC0 Public DomainToday, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels—biomarkers that help predict an
Neurology April 08,2024
Blood test for Alzheimer's disease predicts future cognitive decline in healthy people

Blood test for Alzheimer's disease predicts future cognitive decline in healthy people

by Brigham and Women's HospitalCredit: CC0 Public DomainToday, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels—biomarkers that help predict an
Neurology April 08,2024
Alzheimer's treatment holds promise for primary progressive aphasia patients

Alzheimer's treatment holds promise for primary progressive aphasia patients

by Northwestern UniversityCredit: CC0 Public DomainNorthwestern Medicine scientists have discovered that an existing therapy frequently used to treat Alzheimer's disease might also work on pa
Neurology April 08,2024
Alzheimer's treatment holds promise for primary progressive aphasia patients

Alzheimer's treatment holds promise for primary progressive aphasia patients

by Northwestern UniversityCredit: CC0 Public DomainNorthwestern Medicine scientists have discovered that an existing therapy frequently used to treat Alzheimer's disease might also work on pa
Neurology April 08,2024
Alzheimer's treatment shows unique results

Alzheimer's treatment shows unique results

by Uppsala UniversityDespite his team’s successes, Lars Lannfelt does not want to speculate on when an approved treatment can be available for health care. Credit: Johan WahlgrenIn late July ther
Neurology April 08,2024
Alzheimer's treatment shows unique results

Alzheimer's treatment shows unique results

by Uppsala UniversityDespite his team’s successes, Lars Lannfelt does not want to speculate on when an approved treatment can be available for health care. Credit: Johan WahlgrenIn late July ther
Neurology April 08,2024
An Alzheimer's treatment would tax the US health care system

An Alzheimer's treatment would tax the US health care system

by RAND CorporationThe flow of how an Alzheimer's treatment would get to patients after approval. Credit: RAND Corp.The U.S. health care system lacks the capacity to rapidly move a treatment
Neurology April 08,2024
An Alzheimer's treatment would tax the US health care system

An Alzheimer's treatment would tax the US health care system

by RAND CorporationThe flow of how an Alzheimer's treatment would get to patients after approval. Credit: RAND Corp.The U.S. health care system lacks the capacity to rapidly move a treatment
Neurology April 08,2024
One step closer toward a treatment for Alzheimer's disease?

One step closer toward a treatment for Alzheimer's disease?

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainScientists at the Massachusetts General Hospital (MGH), in collaboration with colleag
Neurology April 08,2024
One step closer toward a treatment for Alzheimer's disease?

One step closer toward a treatment for Alzheimer's disease?

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainScientists at the Massachusetts General Hospital (MGH), in collaboration with colleag
Neurology April 08,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com